TARO - Taro Pharmaceutical Industries Ltd. (TARO) CEO Uday Baldota on Q2 2021 Results - Earnings Call Transcript

Taro Pharmaceutical Industries Ltd. (TARO) Q2 2021 Results Conference Call October 29, 2021 08:00 AM ET Company Participants William Coote - Assistant VP and Treasurer Dilip Shanghvi - Chairman Uday Baldota - CEO Daphne Huang - CFO Conference Call Participants Ram Selvaraju - H.C Wainwright Girish Bakhru - Bank of America Shyam Srinivasan - Goldman Sachs Presentation Operator Good morning, ladies and gentlemen, and welcome to the Taro Pharmaceutical's Second Quarter Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded. I would now like to turn the call over to your host today, Mr. William Coote, Assistant Vice President and Treasurer. Please go ahead, sir. William Coote Thank you. Good morning, everyone, and welcome to our second quarter 2020-'21 earnings conference call. We hope everyone is healthy and safe during these trying times, and since safety is our top priority, we are conducting the virtual

For further details see:

Taro Pharmaceutical Industries Ltd. (TARO) CEO Uday Baldota on Q2 2021 Results - Earnings Call Transcript